Your Education. Our Mission.
Class of 2017
Class of 2016
Class of 2015
Class of 2014
Class of 2013
Class of 2012
Class of 2011
Class of 2010
Class of 2009
Class of 2008
Class of 2007
Class of 2006
Class of 2005
Class of 2004
Class of 2003
Class of 2002
Class of 2001
Class of 2000
Class of 1999
Class of 1998
Class of 1997
Class of 1996
Class of 1995
Class of 1994
Class of 1993
Class of 1992
Class of 1991
The potential applications of mRNA technology are wide-ranging: in a few years it could provide a therapeutic strategy for cancer, cardiovascular or autoimmune diseases.
We would like to inform our users that ClinicalKey Student is available on a trial until 7 June 2024.
Calls for application of the Pannonia Scholarship Program have been announced for long- and short-term student mobilities.